T1	Participants 135 195	quality assurance program of the randomized trial SAKK 09/10
T2	Participants 361 386	recurrent prostate cancer
T3	Participants 447 467	in clinical practice
T4	Participants 491 553	A randomized phase III trial testing 64 Gy vs 70 Gy salvage RT
T5	Participants 1096 1302	Thirty European centers participated, 43% of which were using 3-dimensional conformal RT (3D-CRT), with the remaining centers using intensity modulated RT (IMRT) or volumetric modulated arc technique (VMAT)
